Atrial Fibrillation in Cardiac Sarcoidosis

Area of Science:

• Cardiology
• Immunology
• Systemic Inflammatory Diseases

Background:

• Sarcoidosis is a systemic granulomatous disease with known cardiac manifestations.
• While ventricular arrhythmias are common in cardiac sarcoidosis (CS), atrial arrhythmias, particularly atrial fibrillation, are increasingly recognized.
• The precise incidence and underlying mechanisms of atrial fibrillation in CS remain unclear.

Approach:

• This review synthesizes current literature on atrial fibrillation in cardiac sarcoidosis.
• It examines epidemiological data, potential pathophysiological mechanisms, and current/emerging treatment strategies.
• Focus is placed on the role of immunosuppressive therapy in managing atrial arrhythmias in CS patients.

Key Points:

• Atrial fibrillation is a frequent manifestation of cardiac sarcoidosis, impacting a significant patient subset.
• Current management follows general atrial fibrillation guidelines, but specific CS considerations are evolving.
• Immunosuppression shows promise as an adjunctive therapy for atrial arrhythmias in CS.

Conclusions:

• Atrial fibrillation is a significant clinical issue in cardiac sarcoidosis.
• Further research into the specific mechanisms and optimal management, including immunosuppression, is warranted.
• A multidisciplinary approach is crucial for effectively managing CS patients with atrial fibrillation.